Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers

Documenti analoghi

• Managing Drug–Drug Interactions Involving the Non‐Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling
  di: Zhu Zhou, et al.
  Pubblicazione: (2026)
• Predicting OCT2 / MATEs ‐Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)
  di: Satoshi Asano, et al.
  Pubblicazione: (2025)
• Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug–Drug Interaction Predictions
  di: Kunal S. Taskar, et al.
  Pubblicazione: (2025)
• New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans
  di: Arne Gessner, et al.
  Pubblicazione: (2024)
• EASI Drugs in the Streets of Colombia: Modeling Heterogeneous and Endogenous Drug Preferences
  di: Montoya-Blandón, Santiago, et al.
  Pubblicazione: (2025)